Home » Topics » BioWorld Science, Infection

BioWorld Science, Infection
RSS

SAR and biological profile of FR-86521, a cephalosporin highly active against MRSA

Dec. 11, 1997

Boehringer Mannheim returns to PDL rights to two antiviral compounds

Dec. 9, 1997

FDA approves shorter treatment claim for Mentax

Dec. 9, 1997

MedImmune announces collaborations for MEDI-493

Dec. 8, 1997

Neose's NE-1530 enters phase I for otitis media

Dec. 8, 1997

SKB reveals selective inhibitors of bacterial enzyme

Dec. 5, 1997

Medarex reports novel method for treating infectious disease

Dec. 5, 1997

Method of inactivating RNA viruses offered for licensing

Dec. 4, 1997

Combination malaria vaccine enters phase I

Dec. 3, 1997

Second-generation 2-5A antisense drug with broad-spectrum anti-RSV activity

Dec. 2, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 31, 2026.
New schizophrenia targets challenge trial design
BioWorld
The search for better schizophrenia therapies is moving beyond dopamine toward a growing number of experimental targets. According to researchers, the repeated...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 28, 2026
AIDS 2026: New targets for metabolic dysfunction despite ART
BioWorld
Although antiretroviral therapy (ART) can suppress HIV to undetectable levels, a growing body of evidence suggests that the virus leaves a lasting biological...
Fauci’s silence may put him in contempt of Congress
BioWorld
After repeatedly invoking the Fifth Amendment to every question asked during the July 29 hearing of the U.S. Senate Homeland Security Committee, Anthony Fauci,...